Aptevo Therapeutics Statistics
Total Valuation
APVO has a market cap or net worth of $2.48 million. The enterprise value is $4.76 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
APVO has 676,804 shares outstanding.
Current Share Class | 676,804 |
Shares Outstanding | 676,804 |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +78.66% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 12.19% |
Float | 676,792 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.67
Current Ratio | 0.67 |
Quick Ratio | 0.40 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -1,023.93% and return on invested capital (ROIC) is -201.28%.
Return on Equity (ROE) | -1,023.93% |
Return on Assets (ROA) | -115.99% |
Return on Invested Capital (ROIC) | -201.28% |
Return on Capital Employed (ROCE) | -817.19% |
Revenue Per Employee | n/a |
Profits Per Employee | -$640,649 |
Employee Count | 37 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.36% in the last 52 weeks. The beta is 5.73, so APVO's price volatility has been higher than the market average.
Beta (5Y) | 5.73 |
52-Week Price Change | -99.36% |
50-Day Moving Average | 10.19 |
200-Day Moving Average | 98.64 |
Relative Strength Index (RSI) | 24.17 |
Average Volume (20 Days) | 407,157 |
Short Selling Information
The latest short interest is 9,397, so 1.39% of the outstanding shares have been sold short.
Short Interest | 9,397 |
Short Previous Month | 418,228 |
Short % of Shares Out | 1.39% |
Short % of Float | 1.39% |
Short Ratio (days to cover) | 0.03 |
Income Statement
Revenue | n/a |
Gross Profit | 171,000 |
Operating Income | -24.10M |
Pretax Income | -24.95M |
Net Income | -23.70M |
EBITDA | -23.79M |
EBIT | -24.10M |
Earnings Per Share (EPS) | -$745.27 |
Full Income Statement Balance Sheet
The company has $2.14 million in cash and $4.42 million in debt, giving a net cash position of -$2.28 million or -$3.37 per share.
Cash & Cash Equivalents | 2.14M |
Total Debt | 4.42M |
Net Cash | -2.28M |
Net Cash Per Share | -$3.37 |
Equity (Book Value) | -1.47M |
Book Value Per Share | -20.20 |
Working Capital | -1.79M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -23.71M |
Capital Expenditures | n/a |
Free Cash Flow | -23.71M |
FCF Per Share | -$35.03 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
APVO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -956.92% |
FCF Yield | -957.13% |
Analyst Forecast
The average price target for APVO is $5,920.00, which is 161,648.63% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5,920.00 |
Price Target Difference | 161,648.63% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on May 27, 2025. It was a reverse split with a ratio of 0.05:1.
Last Split Date | May 27, 2025 |
Split Type | Reverse |
Split Ratio | 0.05:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |